Continuous vs Intermittent β-Lactam Antibiotic Infusions in Patients With Sepsis
12.06.2024
0:00
9:57
Joel M. Dulhunty, MD, PhD, Royal Brisbane and Women’s Hospital, and Jason A. Roberts, BPharm, PhD, University of Queensland Centre for Clinical Research, join JAMA Deputy Editor Preeti Malani, MD, MSJ, to discuss the BLING trial that assessed continuous vs intermittent β-lactam antibiotic infusions in patients with sepsis or septic shock.
Related Content:
Więcej odcinków z kanału "JAMA Author Interviews"
Nie przegap odcinka z kanału “JAMA Author Interviews”! Subskrybuj bezpłatnie w aplikacji GetPodcast.